Zura Bio Limited (ZURA) - Latest Market Data

Price & Market Data

Price: $4.36

Daily Change: -$0.08 / 1.83%

Daily Range: $4.32 - $4.55

Market Cap: $413,679,904

Daily Volume: 510,978

Performance Metrics

1 Week: -5.31%

1 Month: -16.64%

3 Months: -28.30%

6 Months: 20.54%

1 Year: 337.3%

YTD: -14.89%

About Zura Bio Limited (ZURA)

Get up-to-date information on Zura Bio Limited (ZURA). The stock is trading at 4.36, with a daily performance indicating a change of -$0.08 / 1.83%. Its market cap is recorded at 413,679,904. Delve into detailed performance metrics, from short-term (1-week) to long-term (1-year) and year-to-date returns.

Company Details

Employees: 40

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.

Selected stocks

Culp, Inc. (CULP)

Ferroglobe PLC (GSM)

Coursera, Inc. (COUR)

Happy City Holdings Limited (HCHL)

China Natural Resources, Inc. (CHNR)